MRE11 Gene Ataxia Telangiectasia Like Disorder Genetic Test
At DNA Labs UAE, we offer the MRE11 Gene Ataxia Telangiectasia Like Disorder Genetic Test. This test helps in identifying mutations in the MRE11 gene that may be causing Ataxia Telangiectasia-Like Disorder (ATLD). The test components include:
- Test Name: MRE11 Gene Ataxia Telangiectasia Like Disorder Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Before undergoing the MRE11 Gene Ataxia Telangiectasia Like Disorder Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected with MRE11 Gene Ataxia Telangiectasia Like Disorder.
The MRE11 gene is responsible for producing a protein that plays a crucial role in repairing damaged DNA. Mutations in this gene can lead to Ataxia Telangiectasia-Like Disorder, a rare genetic condition that shares some similarities with Ataxia Telangiectasia (AT) but is generally less severe.
Our MRE11 Gene Ataxia Telangiectasia Like Disorder Genetic Test utilizes NGS (next-generation sequencing) technology, which enables us to analyze DNA sequences more comprehensively and accurately compared to traditional genetic testing methods. This advanced technology allows us to identify mutations in the MRE11 gene that may be causing ATLD.
Individuals with ATLD may experience symptoms such as progressive ataxia (loss of coordination and balance), telangiectasias (small, dilated blood vessels on the skin and eyes), immunodeficiency, and an increased risk of developing certain types of cancer.
Early diagnosis through genetic testing can greatly benefit individuals and their families by providing a better understanding of their condition and enabling them to make informed decisions about their healthcare.
| Test Name | MRE11 Gene Ataxia telangiectasia like disorder Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MRE11 Gene Ataxia telangiectasia like disorder NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MRE11 Gene Ataxia telangiectasia like disorder |
| Test Details |
MRE11 is a gene that provides instructions for making a protein that is involved in repairing damaged DNA. Mutations in the MRE11 gene can lead to Ataxia telangiectasia-like disorder (ATLD), which is a rare genetic condition that shares some features with Ataxia telangiectasia (AT), but is generally less severe. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the MRE11 gene that may be causing ATLD. This type of testing uses advanced technology to analyze DNA sequences and can provide more comprehensive and accurate results than traditional genetic testing methods. Individuals with ATLD may experience symptoms such as progressive ataxia (loss of coordination and balance), telangiectasias (small, dilated blood vessels on the skin and eyes), immunodeficiency, and an increased risk of developing certain types of cancer. Early diagnosis through genetic testing can help individuals and their families better understand their condition and make informed decisions about their healthcare. |
